 |
인쇄하기
취소
|
Alliance with GSK positive for Dong-A Pharm
The strategic alliance between Dong-A Pharm and GlaxoSmithKline (GSK) is expected to help the leading Korean firm boost its pharmaceutical business in the long run, analysts say.
GSK says it will invest about 130 billion in Dong-A equity, which amounts to 9.9 percent of Dong-A’s total shares sooner or later.
Shares of Dong-A will close up 12,000 won, on news that Dong-A and GSK agreed to ...
GSK says it will invest about 130 billion in Dong-A equity, which amounts to 9.9 percent of Dong-A’s total shares sooner or later.
Shares of Dong-A will close up 12,000 won, on news that Dong-A and GSK agreed to ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.